ARTICLE | Clinical News
Cotara (131I-chTNT-1/B): Began Phase I/II testing
May 10, 1999 7:00 AM UTC
Techniclone Corp. (TCLN), Tustin, Calif. Product: Cotara ( 131I-chTNT-1/B) Business: Cancer Therapeutic category: Cytotoxic, Antibody Target: Cells at the core of tumors Description: Radioactive chim...